Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry-Evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization o
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-06-01
著者
-
Unger Steve
Bioanalytical Sciences Department Pharmaceutical Research Institute
-
Pasas-farmer Stephanie
Bioanalytical Sciences Department Pharmaceutical Research Institute
-
Crane Paul
Bristol-myers Squibb Medical Imaging Group
-
Arnold Mark
Bioanalytical Sciences Department Pharmaceutical Research Institute
-
ZENG Jianing
Bioanalytical Sciences Department, Pharmaceutical Research Institute
-
ONTHANK David
Bristol-Myers Squibb, Medical Imaging Group
-
ZHENG Naiyu
Bioanalytical Sciences Department, Pharmaceutical Research Institute
-
Onthank David
Bristol-myers Squibb Medical Imaging Group
-
Zeng Jianing
Bioanalytical Sciences Department Pharmaceutical Research Institute
-
Zheng Naiyu
Bioanalytical Sciences Department Pharmaceutical Research Institute
関連論文
- Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a γ-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions
- Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry-Evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization o
- Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra^) in human plasma : Method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degra